LeMaitre Vascular Inc (LMAT)
82.28
0.00 (0.00%)
USD |
NASDAQ |
Jun 28, 16:00
82.24
-0.04
(-0.05%)
After-Hours: 20:00
LeMaitre Vascular Research and Development Expense (TTM): 17.18M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 17.18M |
| December 31, 2023 | 16.97M |
| September 30, 2023 | 16.17M |
| June 30, 2023 | 15.41M |
| March 31, 2023 | 14.24M |
| December 31, 2022 | 13.29M |
| September 30, 2022 | 13.20M |
| June 30, 2022 | 12.58M |
| March 31, 2022 | 11.89M |
| December 31, 2021 | 11.80M |
| September 30, 2021 | 11.21M |
| June 30, 2021 | 10.46M |
| March 31, 2021 | 9.95M |
| December 31, 2020 | 10.10M |
| September 30, 2020 | 9.73M |
| June 30, 2020 | 9.913M |
| March 31, 2020 | 10.03M |
| December 31, 2019 | 9.276M |
| September 30, 2019 | 9.124M |
| June 30, 2019 | 8.88M |
| March 31, 2019 | 8.612M |
| December 31, 2018 | 8.197M |
| September 30, 2018 | 7.433M |
| June 30, 2018 | 7.157M |
| March 31, 2018 | 6.803M |
| Date | Value |
|---|---|
| December 31, 2017 | 6.636M |
| September 30, 2017 | 6.575M |
| June 30, 2017 | 6.353M |
| March 31, 2017 | 6.353M |
| December 31, 2016 | 6.141M |
| September 30, 2016 | 6.194M |
| June 30, 2016 | 6.076M |
| March 31, 2016 | 5.773M |
| December 31, 2015 | 5.479M |
| September 30, 2015 | 4.985M |
| June 30, 2015 | 4.673M |
| March 31, 2015 | 4.479M |
| December 31, 2014 | 4.671M |
| September 30, 2014 | 4.992M |
| June 30, 2014 | 5.183M |
| March 31, 2014 | 5.314M |
| December 31, 2013 | 5.243M |
| September 30, 2013 | 5.402M |
| June 30, 2013 | 5.363M |
| March 31, 2013 | 5.23M |
| December 31, 2012 | 5.092M |
| September 30, 2012 | 4.67M |
| June 30, 2012 | 4.383M |
| March 31, 2012 | 4.288M |
| December 31, 2011 | 4.425M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
8.88M
Minimum
Jun 2019
17.18M
Maximum
Mar 2024
12.07M
Average
11.51M
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International Inc | 679.00M |
| AtriCure Inc | 78.43M |
| Becton Dickinson & Co | 1.176B |
| Intuitive Surgical Inc | 1.038B |
| Perspective Therapeutics Inc | 24.91M |